Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02531334 · ClinicalTrials.gov registry record · NA
Effects of TA-65, a Telomerase Activator on Metabolic Syndrome
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02531334 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 40 participants.
The verdict
NCT02531334, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the efficacy of TA-65, a purified extract of Astragalus root, on insulin resistance, oxidative stress, and inflammation in individuals classified with metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT TA-65
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02531334
The ClinicalTrials.gov registry entry for NCT02531334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TA-65 is the first listed.
NCT02531334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02531334 about?
NCT02531334 is a clinical study titled "Effects of TA-65, a Telomerase Activator on Metabolic Syndrome". This study is being conducted to evaluate the efficacy of TA-65, a purified extract of Astragalus root, on insulin resistance, oxidative stress, and inflammation in individuals classified with metabolic syndrome.
What is the current status of trial NCT02531334?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-08. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02531334?
The interventions under investigation include: TA-65 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02531334?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.